Conclusion
Although further studies, including unveiling molecular mechanisms and
clinical trials, are necessary, we can conclude that administration of
supraphysiological doses of T with a rapid drop to castration levels
(BAT) might re-sensitize cancer cells to non-steroidal antiandrogens and
restore resistance to other treatment modalities including ARAT and
cytotoxic chemotherapy.